Common polymorphisms in the age of research domain criteria (RDoC): Integration and translation

Biological Psychiatry

Volumn 79, Issue 1, 2016, Pages 25-31

  Glatt, Charles E ^a   Lee, Francis S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anxiety; BDNF Val66Met; Behavioral dimension; Common polymorphism; Fear learning; Genetic biomarker

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

AGING; CLINICAL PRACTICE; CLINICAL RESEARCH; FEAR; GENE INTERACTION; GENETIC VARIABILITY; LEARNING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; ANIMAL; BEHAVIOR; DISEASE MODEL; GENE TARGETING; GENETIC POLYMORPHISM; GENETICS; HUMAN; MENTAL DISORDERS; MOUSE;

ANIMALS; BEHAVIOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; HUMANS; MENTAL DISORDERS; MICE; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 84948458945     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.12.020     Document Type: Review

References (75)

1. T.R. Insel The NIMH Research Domain Criteria (RDoC) Project: Precision medicine for psychiatry Am J Psychiatry 171 2014 395 397
2. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature 511 2014 421 427
3. B. Devlin, and S.W. Scherer Genetic architecture in autism spectrum disorder Curr Opin Genet Dev 22 2012 229 237
4. J. Gratten, N.R. Wray, M.C. Keller, and P.M. Visscher Large-scale genomics unveils the genetic architecture of psychiatric disorders Nat Neurosci 17 2014 782 790
5. N. Risch, and K. Merikangas The future of genetic studies of complex human diseases Science 273 1996 1516 1517
6. F.S. Collins, M.S. Guyer, and A. Charkravarti Variations on a theme: Cataloging human DNA sequence variation Science 278 1997 1580 1581
7. E.S. Lander The new genomics: Global views of biology Science 274 1996 536 539
8. D.E. Reich, and E.S. Lander On the allelic spectrum of human disease Trends Genet 17 2001 502 510
9. N.R. Wray, and P.M. Visscher Narrowing the boundaries of the genetic architecture of schizophrenia Schizophr Bull 36 2010 14 23
10. C.M. Lewis, M.Y. Ng, A.W. Butler, S. Cohen-Woods, R. Uher, K. Pirlo, and et al. Genome-wide association study of major recurrent depression in the U.K. population Am J Psychiatry 167 2010 949 957
11. S.E. Stewart, D. Yu, J.M. Scharf, B.M. Neale, J.A. Fagerness, C.A. Mathews, and et al. Genome-wide association study of obsessive-compulsive disorder Mol Psychiatry 18 2013 788 798
12. Z.R. Donaldson, and R. Hen From psychiatric disorders to animal models: A bidirectional and dimensional approach Biol Psychiatry 77 2015 15 21
13. C.P. Austin, J.F. Battey, A. Bradley, M. Bucan, M. Capecchi, F.S. Collins, and et al. The knockout mouse project Nat Genet 36 2004 921 924
14. E.J. Nestler, and S.E. Hyman Animal models of neuropsychiatric disorders Nat Neurosci 13 2010 1161 1169
15. E.J. Huang, and L.F. Reichardt Neurotrophins: Roles in neuronal development and function Annu Rev Neurosci 24 2001 677 736
16. K. Yamada, and T. Nabeshima Brain-derived neurotrophic factor/TrkB signaling in memory processes J Pharmacol Sci 91 2003 267 270
17. G. Nagappan, and B. Lu Activity-dependent modulation of the BDNF receptor TrkB: Mechanisms and implications Trends Neurosci 28 2005 464 471
18. - 1000 Genomes Project Consortium, G.R. Abecasis, D. Altshuler, A. Auton, L.D. Brooks, R.M. Durbin, and et al. A map of human genome variation from population-scale sequencing Nature 467 2010 1061 1073
19. Z.Y. Chen, A. Ieraci, H. Teng, H. Dall, C.X. Meng, D.G. Herrera, and et al. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway J Neurosci 25 2005 6156 6166
20. Z.Y. Chen, D. Jing, K.G. Bath, A. Ieraci, T. Khan, C.J. Siao, and et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior Science 314 2006 140 143
21. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, and et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
22. I. Dincheva, C.E. Glatt, and F.S. Lee Impact of the BDNF Val66Met polymorphism on cognition: Implications for behavioral genetics Neuroscientist 18 2012 439 451
23. L. Pezawas, B.A. Verchinski, V.S. Mattay, J.H. Callicott, B.S. Kolachana, R.E. Straub, and et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology J Neurosci 24 2004 10099 10102
24. J. LeDoux Fear and the brain: Where have we been, and where are we going? Biol Psychiatry 44 1998 1229 1238
25. J.E. LeDoux Emotion circuits in the brain Annu Rev Neurosci 23 2000 155 184
26. S. Maren, K.L. Phan, and I. Liberzon The contextual brain: Implications for fear conditioning, extinction and psychopathology Nat Rev Neurosci 14 2013 417 428
27. R.G. Parsons, and K.J. Ressler Implications of memory modulation for post-traumatic stress and fear disorders Nat Neurosci 16 2013 146 153
28. A. Holmes, and N. Singewald Individual differences in recovery from traumatic fear Trends Neurosci 36 2013 23 31
29. J.C. Britton, S. Lissek, C. Grillon, M.A. Norcross, and D.S. Pine Development of anxiety: The role of threat appraisal and fear learning Depress Anxiety 28 2011 5 17
30. U. Vaidyanathan, C.J. Patrick, and B.N. Cuthbert Linking dimensional models of internalizing psychopathology to neurobiological systems: Affect-modulated startle as an indicator of fear and distress disorders and affiliated traits Psychol Bull 135 2009 909 942
31. F. Soliman, C.E. Glatt, K.G. Bath, L. Levita, R.M. Jones, S.S. Pattwell, and et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human Science 327 2010 863 866
32. K.A. Corcoran, and G.J. Quirk Recalling safety: Cooperative functions of the ventromedial prefrontal cortex and the hippocampus in extinction CNS Spectr 12 2007 200 206
33. M.R. Milad, C.I. Wright, S.P. Orr, R.K. Pitman, G.J. Quirk, and S.L. Rauch Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert Biol Psychiatry 62 2007 446 454
34. I. Ninan Synaptic regulation of affective behaviors; role of BDNF Neuropharmacology 76 2014 684 695
35. S.S. Pattwell, K.G. Bath, R. Perez-Castro, F.S. Lee, M.V. Chao, and I. Ninan The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex J Neurosci 32 2012 2410 2421
36. B.J. Casey, M.E. Oliveri, and T. Insel A neurodevelopmental perspective on the research domain criteria (RDoC) framework Biol Psychiatry 76 2014 350 353
37. J. McCallum, J.H. Kim, and R. Richardson Impaired extinction retention in adolescent rats: Effects of D-cycloserine Neuropsychopharmacology 35 2010 2134 2142
38. S.S. Pattwell, S. Duhoux, C.A. Hartley, D.C. Johnson, D. Jing, M.D. Elliott, and et al. Altered fear learning across development in both mouse and human Proc Natl Acad Sci U S A 109 2012 16318 16323
39. B.J. Casey, and R.M. Jones Neurobiology of the adolescent brain and behavior: Implications for substance use disorders J Am Acad Child Adolesc Psychiatry 49 2010 1189 1201 quiz 1285
40. B.J. Casey, R.M. Jones, L. Levita, V. Libby, S.S. Pattwell, E.J. Ruberry, and et al. The storm and stress of adolescence: Insights from human imaging and mouse genetics Dev Psychobiol 52 2010 225 235
41. R.C. Kessler, O. Demler, R.G. Frank, M. Olfson, H.A. Pincus, E.E. Walters, and et al. Prevalence and treatment of mental disorders, 1990 to 2003 N Engl J Med 352 2005 2515 2523
42. S.S. Pattwell, K.G. Bath, B.J. Casey, I. Ninan, and F.S. Lee Selective early-acquired fear memories undergo temporary suppression during adolescence Proc Natl Acad Sci U S A 108 2011 1182 1187
43. S.S. Pattwell, F.S. Lee, and B.J. Casey Fear learning and memory across adolescent development: Hormones and Behavior Special Issue: Puberty and Adolescence Horm Behav 64 2013 380 389
44. I. Dincheva, S.S. Pattwell, L. Tessarollo, K.G. Bath, and F.S. Lee BDNF modulates contextual fear learning during adolescence Dev Neurosci 36 2014 269 276
45. K.G. Bath, J. Chuang, J.L. Spencer-Segal, D. Amso, M. Altemus, B.S. McEwen, and F.S. Lee Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice Biol Psychiatry 72 2012 499 504
46. B.S. McEwen, L. Eiland, R.G. Hunter, and M.M. Miller Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress Neuropharmacology 62 2012 3 12
47. S.J. Lupien, B.S. McEwen, M.R. Gunnar, and C. Heim Effects of stress throughout the lifespan on the brain, behaviour and cognition Nat Rev Neurosci 10 2009 434 445
48. H. Yu, D.D. Wang, Y. Wang, T. Liu, F.S. Lee, and Z.Y. Chen Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants J Neurosci 32 2012 4092 4101
49. R.P. Juster, G. Bizik, M. Picard, G. Arsenault-Lapierre, S. Sindi, L. Trepanier, and et al. A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development Dev Psychopathol 23 2011 725 776
50. O. Gunduz-Cinar, M.N. Hill, B.S. McEwen, and A. Holmes Amygdala FAAH and anandamide: Mediating protection and recovery from stress Trends Pharmacol Sci 34 2013 637 644
51. O. Gunduz-Cinar, K.P. MacPherson, R. Cinar, J. Gamble-George, K. Sugden, B. Williams, and et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity Mol Psychiatry 18 2013 813 823
52. J.P. Chhatwal, M. Davis, K.A. Maguschak, and K.J. Ressler Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear Neuropsychopharmacology 30 2005 516 524
53. J.C. Sipe, K. Chiang, A.L. Gerber, E. Beutler, and B.F. Cravatt A missense mutation in human fatty acid amide hydrolase associated with problem drug use Proc Natl Acad Sci U S A 99 2002 8394 8399
54. K.P. Chiang, A.L. Gerber, J.C. Sipe, and B.F. Cravatt Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use Hum Mol Genet 13 2004 2113 2119
55. I. Dincheva, A.T. Drysdale, C.A. Hartley, D.C. Johnson, D. Jing, E.C. King, and et al. FAAH genetic variation enhances frontoamygdala function in mouse and human Nat Commun 2015 March 3;6:6395.
56. J. Ott Association of genetic loci: Replication or not, that is the question Neurology 63 2004 955 958
57. N. Risch, R. Herrell, T. Lehner, K.Y. Liang, L. Eaves, J. Hoh, and et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis JAMA 301 2009 2462 2471
58. K. Karg, M. Burmeister, K. Shedden, and S. Sen The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation Arch Gen Psychiatry 68 2011 444 454
59. J.W. Wang, A. Dranovsky, and R. Hen The when and where of BDNF and the antidepressant response Biol Psychiatry 63 2008 640 641
60. E. Castren, and T. Rantamaki The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity Dev Neurobiol 70 2010 289 297
61. T. Jovanovic, and K.J. Ressler How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD Am J Psychiatry 167 2010 648 662
62. A.T. Drysdale, C.A. Hartley, S.S. Pattwell, E.J. Ruberry, L.H. Somerville, S.N. Compton, and et al. Fear and anxiety from principle to practice: Implications for when to treat youth with anxiety disorders Biol Psychiatry 75 2014 e19 e20
63. K.L. Felmingham, C. Dobson-Stone, P.R. Schofield, G.J. Quirk, and R.A. Bryant The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder Biol Psychiatry 73 2013 1059 1063
64. S.D. Mague, and J.A. Blendy OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models Drug Alcohol Depend 108 2010 172 182
65. S.D. Mague, C. Isiegas, P. Huang, L.Y. Liu-Chen, C. Lerman, and J.A. Blendy Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior Proc Natl Acad Sci U S A 106 2009 10847 10852
66. Y.J. Wang, P. Huang, A. Ung, J.A. Blendy, and L.Y. Liu-Chen Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G Neuroscience 205 2012 178 184
67. Y. Zhang, R. Picetti, E.R. Butelman, A. Ho, J.A. Blendy, and M.J. Kreek Mouse model of the OPRM1 (A118G) polymorphism: Differential heroin self-administration behavior compared with wild-type mice [published online ahead of print October 22] Neuropsychopharmacology. 2014
68. L. Hosak Role of the COMT gene Val158Met polymorphism in mental disorders: A review Eur Psychiatry 22 2007 276 281
69. M. Cai, and Y. Yang Targeted genome editing tools for disease modeling and gene therapy Curr Gene Ther 14 2014 2 9
70. J.K. Cheng, and H.S. Alper The genome editing toolbox: A spectrum of approaches for targeted modification Curr Opin Biotechnol 30C 2014 87 94
71. J.K. Joung, and J.D. Sander TALENs: A widely applicable technology for targeted genome editing Nat Rev Mol Cell Biol 14 2013 49 55
72. H. Wang, H. Yang, C.S. Shivalila, M.M. Dawlaty, A.W. Cheng, F. Zhang, and R. Jaenisch One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering Cell 153 2013 910 918
73. A. Mitchison Partitioning of genetic variation between regulatory and coding gene segments: The predominance of software variation in genes encoding introvert proteins Immunogenetics 46 1997 46 52
74. R. Gerlai Phenomics: Fiction or the future? Trends Neurosci 25 2002 506 509
75. R.M. Bilder, F.W. Sabb, T.D. Cannon, E.D. London, J.D. Jentsch, D.S. Parker, and et al. Phenomics: The systematic study of phenotypes on a genome-wide scale Neuroscience 164 2009 30 42